Toronto, Canada (PRWEB) July 17, 2013
This webinar will focus on the regulatory requirements and expectancies for the conduct of studies to support the scheduling of new chemical entities. Industry expert Mary Jeanne Kallman, Ph.D., Director of Nonclinical Global Neuroscience at Covance will provide perspectives on past approaches to scheduling as well as an overview of the three study types; dependence, drug discrimination, and self-administration.
This webinar will also discuss the results of abuse liability studies, which are being used to make recommendations about scheduling in the form of an 8-factor document. The 8-factor document will include both clinical and preclinical data. This webinar will emphasize decision-making points and how to design these studies to meet the FDA and EMA requirements.
To learn more about the event, visit:http://www.xtalks.com/addressing-scientific-and-regulatory-challenges.ashx
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx
Karen Lim (416) 977-6555 ext 227
Read the full story at http://www.prweb.com/releases/2013/7/prweb10925078.htm.
Copyright©2012 Vocus, Inc.
All rights reserved